Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




International Approvals: Isentress, Rexin-G, Vectibix
Link ID 2168
Title International Approvals: Isentress, Rexin-G, Vectibix
Url http://www.medscape.com/viewarticle/568338?src=rss
Description Europe has approved raltegravir tablets (Isentress); the Philippines has approved a tumor-targeted gene delivery product (Rexin-G); and Europe has approved panitumumab intravenous infusion (Vectibix). Medscape Medical News
Category Articles > Business of Medicine
Keywords
Date Jan 8, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. Number of Uninsured U.S. Young Adults Grows: Study
  The number of uninsured U.S. young adults, who already represent a major chunk of the American population without health coverage, rose again in 2006, according to a study released on Friday. Reuters Health Information
Category:   Articles > Business of Medicine


2. Does Medical Research Help Us Make Better Clinical Decisions?
  To be clinically relevant, statistics have to be expressed in terms that mean something in the clinic and that can be used in decision-making.
Medscape Business of Medicine
Category:   Articles > Business of Medicine


3. Adenosine Agonist for Stress Perfusion Imaging Approved
  The US Food and Drug Administration has market-approved regadenoson (Lexiscan), a selective A2A adenosine-receptor agonist, for resting stress-myocardial perfusion scans. Heartwire
Category:   Articles > Business of Medicine


4. Which Resuscitation Guidelines Should Be Used For Neonates Beyond the Delivery Room?
  Is it necessary to train emergency department and pediatric department staff in the Neonatal Resuscitation Program in addition to Pediatric Advanced Life Support? How do these programs differ?
Medscape Nurses
Category:   Articles > Business of Medicine


5. Experts Welcome Accelerated Approval of Bevacizumab for Breast Cancer
  Bevacizumab has received accelerated approval from the US Food and Drug Administration for use in metastatic breast cancer in combination with paclitaxel chemotherapy. Medscape Medical News
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS